Rising Burden of Psychiatric and Behavioral Disorders and Their Adverse Impact on Health Care Expenditure in Hospitalized Pediatric Patients with Inflammatory Bowel Disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The incidence and prevalence of inflammatory bowel disease (IBD) are increasing along with an increasing number of patients with comorbid conditions like psychiatric and behavioral disorders, which are independent predictors of quality of life. Methods: Non-overlapping years (2003-2016) of National Inpatient Sample and Kids Inpatient Database were analyzed to include all IBD-related hospitalizations of patients less than 21 years of age. Patients were analyzed for a concomitant diagnosis of psychiatric/ behavioral disorders and were compared with IBD patients without psychiatric/behavioral disorder diagnoses for outcome variables: IBD severity, length of stay and inflation-adjusted hospitalization charges. Results: Total of 161,294 IBD-related hospitalizations were analyzed and the overall prevalence rate of any psychiatric and behavioral disorders was 15.7%. Prevalence rate increased from 11.3% (2003) to 20.6% (2016), p<0.001. Depression, substance use, and anxiety were the predominant psychiatric disorders. Regression analysis showed patients with severe IBD (odds ratio [OR], 1.57; confidence interval [CI], 1.47-1.67; p<0.001) and intermediate IBD (OR, 1.14; CI, 1.10-1.28, p<0.001) had increased risk of associated psychiatric and behavioral disorders than patients with a low severity IBD. Multivariate analysis showed that psychiatric and behavioral disorders had 1.17 (CI, 1.07-1.28; p<0.001) mean additional days of hospitalization and incurred additional $8473 (CI, 7,520-9,425; p<0.001) of mean hospitalization charges, independent of IBD severity. Conclusion: Prevalence of psychiatric and behavioral disorders in hospitalized pediatric IBD patients has been significantly increasing over the last two decades, and these disorders were independently associated with prolonged hospital stay, and higher total hospitalization charges.
Abstract
Purpose: The incidence and prevalence of inflammatory bowel disease (IBD) are increasing along with an increasing number of patients with comorbid conditions like psychiatric and behavioral disorders, which are independent predictors of quality of life. Methods: Non-overlapping years (2003-2016) of National Inpatient Sample and Kids Inpatient Database were analyzed to include all IBD-related hospitalizations of patients less than 21 years of age. Patients were analyzed for a concomitant diagnosis of psychiatric/ behavioral disorders and were compared with IBD patients without psychiatric/behavioral disorder diagnoses for outcome variables: IBD severity, length of stay and inflation-adjusted hospitalization charges. Results: Total of 161,294 IBD-related hospitalizations were analyzed and the overall prevalence rate of any psychiatric and behavioral disorders was 15.7%. Prevalence rate increased from 11.3% (2003) to 20.6% (2016), p<0.001. Depression, substance use, and anxiety were the predominant psychiatric disorders. Regression analysis showed patients with severe IBD (odds ratio [OR], 1.57; confidence interval [CI], 1.47-1.67; p<0.001) and intermediate IBD (OR, 1.14; CI, 1.10-1.28, p<0.001) had increased risk of associated psychiatric and behavioral disorders than patients with a low severity IBD. Multivariate analysis showed that psychiatric and behavioral disorders had 1.17 (CI, 1.07-1.28; p<0.001) mean additional days of hospitalization and incurred additional $8473 (CI, 7,520-9,425; p<0.001) of mean hospitalization charges, independent of IBD severity. Conclusion: Prevalence of psychiatric and behavioral disorders in hospitalized pediatric IBD patients has been significantly increasing over the last two decades, and these disorders were independently associated with prolonged hospital stay, and higher total hospitalization charges.
참고문헌 (23)
- Ng SC, "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century : a systematic review of population-based studies", Lancet, 390, pp.2769~2778 (2017)
- Coward S, "Past and future burden of inflammatory bowel diseases based on modeling of population-based data", Gastroenterology, 156, pp.1345~1353 (2019)
- Aravind Thavamani, "Burden of Psychiatric Disorders among Pediatric and Young Adults with Inflammatory Bowel Disease: A Population-Based Analysis", Pediatric Gastroenterology, Hepatology & Nutrition, 22(6), pp.527~535 (2019), 대한소아소화기영양학회[DOI]
- Butwicka A, "Association of childhoodonset inflammatory bowel disease with risk of psychiatric disorders and suicide attempt", JAMA Pediatr, 173, pp.969~978 (2019)
- Martone G, "The inflammation hypothesis and mental illness", J Clin Psychiatr Neurosci, 2, pp.3~12 (2019)
- Reichenberg A, "Cytokine-associated emotional and cognitive disturbances in humans", Arch Gen Psychiatry, 58, pp.445~452 (2001)
- Rao U, "Biomarkers in pediatric depression", Depress Anxiety, 30, pp.787~791 (2013)
- Engelmann G, "Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity", Child Psychiatry Hum Dev, 46, pp.300~307 (2015)
- Guthrie E, "Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease", Am J Gastroenterol, 97, pp.1994~1999 (2002)
- Rufo PA, "Health supervision in the management of children and adolescents with IBD : NASPGHAN recommendations", J Pediatr Gastroenterol Nutr, 55, pp.93~108 (2012)
- Mackner LM, "Psychosocial issues in pediatric inflammatory bowel disease : report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition", J Pediatr Gastroenterol Nutr, 56, pp.449~458 (2013)
- "Description of data elements" (2022)[URL]
- Ananthakrishnan AN, "A novel risk score to stratify severity of Crohn’s disease hospitalizations", Am J Gastroenterol, 105, pp.1799~1807 (2010)
- Ananthakrishnan AN, "Simple score to identify colectomy risk in ulcerative colitis hospitalizations", Inflamm Bowel Dis, 16, pp.1532~1540 (2010)
- Szigethy E, "Mental health costs of inflammatory bowel diseases", Inflamm Bowel Dis, 27, pp.40~48 (2021)
- Szigethy E, "Depressive symptoms and inflammatory bowel disease in children and adolescents : a cross-sectional study", J Pediatr Gastroenterol Nutr, 39, pp.395~403 (2004)
- Narula N, "Anxiety but not depression predicts poor outcomes in inflammatory bowel disease", Inflamm Bowel Dis, 25, pp.1255~1261 (2019)
- Gray WN, "Treatment adherence in adolescents with inflammatory bowel disease : the collective impact of barriers to adherence and anxiety", depressive symptoms, 2012, pp.37, 282~291
- Lee EJ, "Psychiatric conditions are associated with medical noncompliance and worsening disease course in IBD patient population", Am J Gastroenterol, 113(Supple 1), pp.S20~ (2018)
- Patel PV, "Depression predicts prolonged length of hospital stay in pediatric inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 69, pp.570~574 (2019)
- Ali H, "Relation between inflammatory bowel disease, depression, and inpatient outcomes in the United States", Proc(Bayl Univ Med Cent), 35, pp.278~283 (2022)
- Marrie RA, "Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease", J Psychosom Res, 89, pp.107~113 (2016)
- Bernstein CN, "Increased burden of psychiatric disorders in inflammatory bowel disease", Inflamm Bowel Dis, 25, pp.360~368 (2019)